These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7965968)

  • 1. Decline in deaths from rhesus haemolytic disease of the newborn.
    Clarke C; Hussey RM
    J R Coll Physicians Lond; 1994; 28(4):310-1. PubMed ID: 7965968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
    Contreras M
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
    [No Abstract]   [Full Text] [Related]  

  • 5. Deaths from haemolytic disease of the newborn.
    MacKenzie IZ; Bowell PJ; Selinger M
    BMJ; 1992 May; 304(6835):1175-6. PubMed ID: 1392802
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 8. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 11. The prevention and management of haemolytic disease of the newborn.
    Contreras M; de Silva M
    J R Soc Med; 1994 May; 87(5):256-8. PubMed ID: 8207718
    [No Abstract]   [Full Text] [Related]  

  • 12. The history of rhesus prophylaxis with anti-D.
    Wegmann A; Glück R
    Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 14. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
    Harkness M; Freer Y; Prescott RJ; Warner P
    Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemolytic disease of the newborn--the changing scene.
    Tovey LA
    Br J Obstet Gynaecol; 1986 Sep; 93(9):960-6. PubMed ID: 3094573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of Rhesus isoimmunization. Viewpoint of the obstetrician].
    Langer B
    Arch Pediatr; 1998 Nov; 5(11):1269-73. PubMed ID: 9853068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is it advisable to produce anti-Rh0(D) immunoglobulin for the prevention of hemolytic disease of the newborn? (apropos the article by A. A. Mikhaĭlova and N. Ia. Klimova)].
    Olovnikova NI; Chertkov IL
    Gematol Transfuziol; 1993 Mar; 38(3):38-40. PubMed ID: 8020736
    [No Abstract]   [Full Text] [Related]  

  • 20. Rh(D) haemolytic disease of the newborn: the changing scene.
    Urbaniak SJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.